ACNU Switch And IND Exemption Final Rules Targeted For October In FDA Regulatory Goals

Semi-annual regulatory agenda of non-binding target dates also sets December goal for an NPRM to recognize N-acetyl-L-cysteine as a lawful dietary ingredient. Like IND exemptions rule, item on NAC included for first time in FDA’s list.

• Source: Shutterstock

The US Food and Drug Administration’s latest regulatory goals update includes October as the target date for publishing final rules on moving more drug ingredients to OTC and on exemptions from investigational new drug clearance for clinical trials to evaluate food, dietary supplements or cosmetics.

More from Regulation

US FDA Reorganization Set Stage To Improve Food Programs, But Slim Budget Grabs Spotlight

 

“It's kind of a free for all,” says longtime FDA funding advocate Steven Grossman. FDA knew funding it requested “was totally inadequate to the needs. So, Food Chemical Safety is stuck there with about six or eight other purposes the money could have been used for.

US Supplement Industry Needs Relief From ‘Drug Preclusion’ Policy, CRN Reminds FDA

 

CRN petition argues against general preclusion while NPA petition addressed specifically FDA’s wielding of the provision to prohibit the use of NMN supplements available in US. “FDA has acknowledged that they really can't answer one without answering. The two are inextricably linked,” says CRN CEO Steve Mister.

Red Yeast Rice Supplements Facing EU Ban Following Safety Review

 
• By 

Supplements already under close scrutiny in the EU have been linked to severe adverse effects on the musculoskeletal system and liver, even at low doses.

PAGB Launches E-Learning Platform Including CBD ‘Deep Dive’

 
• By 

UK industry association is offering online courses on subjects ranging from UK medicines regulations basics to deep dives on complex topics such as CBD.

More from Policy & Regulation

HHS Secretary Kennedy Directs FDA To Consider Axing Self-Affirmed GRAS ‘Loophole’

 

Eliminating self-affirmation process would require companies to publicly notify FDA of their intended use of ingredients and provide safety data before they’re introduced. Kennedy says the process is “a loophole” for introducing ingredients and chemicals “with unknown safety data.”

Red Yeast Rice Supplements Facing EU Ban Following Safety Review

 
• By 

Supplements already under close scrutiny in the EU have been linked to severe adverse effects on the musculoskeletal system and liver, even at low doses.

Old Problem Of Drugs In Supplements Welcomes US FDA’s Acting Food Chief To New Program

 

Kyle Diamantas was a partner with the Jones Day firm when he was tabbed as acting deputy commissioner to lead the FDA’s Human Foods Program, established in the agency’s reorganization which became effective in October.